Aimia (AIM) Q3 2024 earnings summary

Executive summary

• Achieved consolidated Q3 2024 revenue of $129.1M, up 13% year-over-year, with strong performance from core holdings Bozzetto and Cortland despite macroeconomic and logistical headwinds.

• Adjusted EBITDA rose 55% to $15.0M, driven by cost reductions, operational improvements, and the StarChem acquisition.

• Net loss narrowed to $1.9M, including settlement and tax expenses.

• Settlement and cooperation agreement reached with largest shareholder Mithaq, resulting in board expansion and strategic alignment.

• Strategic Review Committee formed to explore value-unlocking options, including sale, merger, or recapitalization of core holdings.

Financial highlights

• Q3 2024 revenue was $129.1M, up from $114.3M in Q3 2023; gross profit increased 55% to $35.4M, with margin improving to 27.4%.

• Adjusted EBITDA increased to $15.0M from $9.7M; net loss improved to $(1.9)M from $(34.4)M.

• EPS loss reduced to $(0.07) from $(0.45) year-over-year.

• Cash and marketable securities at quarter-end totaled $121.4M, up from $114.6M in Q2.

• Paid $3.9M in preferred share dividends; quarterly dividend payments increased by $600,000 starting Q2 2024.

Outlook and guidance

• On track to meet full-year guidance for combined Adjusted EBITDA of $80–$85M for Bozzetto and Cortland, at the lower end of the range.

• Corporate operating costs for 2024 anticipated at approximately $13M, excluding one-time expenses.

• Cost management and liquidity preservation prioritized due to anticipated cash outflows for Bozzetto loan repayments in Q4.